Related references
Note: Only part of the references are listed.Faulty autolysosome acidification in Alzheimer's disease mouse models induces autophagic build-up of Aβ in neurons, yielding senile plaques
Ju-Hyun Lee et al.
NATURE NEUROSCIENCE (2022)
Isoform- and cell-state-specific lipidation of ApoE in astrocytes
Karina Lindner et al.
CELL REPORTS (2022)
Drug therapies for chronic conditions and risk of Alzheimer's disease and related dementias: A scoping review
Johanna Thunell et al.
ALZHEIMERS & DEMENTIA (2021)
Effect of Acid Suppressants on the Risk of COVID-19: A Propensity Score-Matched Study Using UK Biobank
Xiude Fan et al.
GASTROENTEROLOGY (2021)
Regular use of proton pump inhibitors and risk of type 2 diabetes: results from three prospective cohort studies
Jinqiu Yuan et al.
GUT (2021)
No Association Linking Short-Term Proton Pump Inhibitor Use to Dementia: Systematic Review and Meta-analysis of Observational Studies
Muhammad Ali Khan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
Proton pump inhibitors act with unprecedented potencies as inhibitors of the acetylcholine biosynthesizing enzyme-A plausible missing link for their association with incidence of dementia
Rajnish Kumar et al.
ALZHEIMERS & DEMENTIA (2020)
Molecular pathways driving omeprazole nephrotoxicity
Miguel Fontecha-Barriuso et al.
REDOX BIOLOGY (2020)
Cognitive performance and functional outcomes of carriers of pathogenic copy number variants: analysis of the UK Biobank
Kimberley M. Kendall et al.
BRITISH JOURNAL OF PSYCHIATRY (2019)
Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies
T. N. Poly et al.
OSTEOPOROSIS INTERNATIONAL (2019)
Predicting incident dementia 3-8 years after brief cognitive tests in the UK Biobank prospective study of 500,000 people
Catherine M. Calvin et al.
ALZHEIMERS & DEMENTIA (2019)
Long-term use of proton pump inhibitors, dose-response relationship and associated risk of ischemic stroke and myocardial infarction
T. S. G. Sehested et al.
JOURNAL OF INTERNAL MEDICINE (2018)
Proton Pump Inhibitor Use and Dementia Risk: Prospective Population-Based Study
Shelly L. Gray et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2018)
Prevalence of the apolipoprotein E epsilon 4 allele in amyloid beta positive subjects across the spectrum of Alzheimer's disease
Niklas Mattsson et al.
ALZHEIMERS & DEMENTIA (2018)
Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts
Rachel F. Buckley et al.
ALZHEIMERS & DEMENTIA (2018)
A Nationwide Population-Based Cohort Study of Dementia Risk Among Acid Suppressant Users
In Cheol Hwang et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2018)
Associations of Combined Genetic and Lifestyle Risks With Incident Cardiovascular Disease and Diabetes in the UK Biobank Study
M. Abdullah Said et al.
JAMA CARDIOLOGY (2018)
Proton Pump Inhibitor Use and Risk of Developing Alzheimer's Disease or Vascular Dementia: A Case-Control Analysis
Patrick Imfeld et al.
DRUG SAFETY (2018)
The UK Biobank resource with deep phenotyping and genomic data
Clare Bycroft et al.
NATURE (2018)
The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association
Daniel E. Freedberg et al.
GASTROENTEROLOGY (2017)
Proton Pump Inhibitors Decrease Soluble fms-Like Tyrosine Kinase-1 and Soluble Endoglin Secretion, Decrease Hypertension, and Rescue Endothelial Dysfunction
Kenji Onda et al.
HYPERTENSION (2017)
Proton Pump Inhibitors and Risk of Mild Cognitive Impairment and Dementia
Felicia C. Goldstein et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2017)
Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan
Shu-Yu Tai et al.
PLOS ONE (2017)
Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease A Meta-analysis
Scott C. Neu et al.
JAMA NEUROLOGY (2017)
No Association Between Proton Pump Inhibitor Use and Risk of Alzheimer's Disease
Heidi Taipale et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
The worldwide costs of dementia 2015 and comparisons with 2010
Anders Wimo et al.
ALZHEIMERS & DEMENTIA (2017)
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection
William D. Chey et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Continued Questions About Whether Avoidance of Proton Pump Inhibitors Can Reduce Risk of Dementia
Alireza Atri et al.
GASTROENTEROLOGY (2016)
Risk factors for dementia diagnosis in German primary care practices
Anke Booker et al.
INTERNATIONAL PSYCHOGERIATRICS (2016)
Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease
Benjamin Lazarus et al.
JAMA INTERNAL MEDICINE (2016)
Association of Proton Pump Inhibitors With Risk of Dementia A Pharmacoepidemiological Claims Data Analysis
Willy Gomm et al.
JAMA NEUROLOGY (2016)
Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults
Shannon L. Risacher et al.
JAMA NEUROLOGY (2016)
Trends in Prescription Drug Use Among Adults in the United States From 1999-2012
Elizabeth D. Kantor et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Cognitive impact after short-term exposure to different proton pump inhibitors: assessment using CANTAB software
Sanjida Akter et al.
ALZHEIMERS RESEARCH & THERAPY (2015)
UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age
Cathie Sudlow et al.
PLOS MEDICINE (2015)
Proton pump inhibitor-related headaches: A nationwide population-based case-crossover study in Taiwan
Jen-Feng Liang et al.
CEPHALALGIA (2015)
Risk of dementia in elderly patients with the use of proton pump inhibitors
Britta Haenisch et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2015)
The global prevalence of dementia: A systematic review and metaanalysis
Martin Prince et al.
ALZHEIMERS & DEMENTIA (2013)
Proton Pump Inhibitor and Histamine 2 Receptor Antagonist Use and Vitamin B12 Deficiency
Jameson R. Lam et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Chia-Chan Liu et al.
NATURE REVIEWS NEUROLOGY (2013)
The Proton-Pump Inhibitor Lansoprazole Enhances Amyloid Beta Production
Nahuai Badiola et al.
PLOS ONE (2013)
Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection
C. Bavishi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Proton-Pump Inhibitors Are Associated With Increased Cardiovascular Risk Independent of Clopidogrel Use A Nationwide Cohort Study
Mette Charlot et al.
ANNALS OF INTERNAL MEDICINE (2010)
Selective Interaction of Lansoprazole and Astemizole with Tau Polymers: Potential New Clinical Use in Diagnosis of Alzheimer's Disease
Leonel E. Rojo et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
MECHANISMS OF DISEASE Alzheimer's Disease
Henry W. Querfurth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Live imaging of neuronal degradation by microglia reveals a role for v0-ATPase a1 in phagosomal fusion in vivo
Francesca Peri et al.
CELL (2008)
Epistasis - the essential role of gene interactions in the structure and evolution of genetic systems
Patrick C. Phillips
NATURE REVIEWS GENETICS (2008)
Activation of microglia acidifies lysosomes and leads to degradation of Alzheimer amyloid fibrils
Amitabha Majumdar et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Long-term use of acid suppression started inappropriately during hospitalization
DA Zink et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors
JM Shin et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2004)
Determination and pharmacokinetic profile of omeprazole in rat blood, brain and bile by microdialysis and high-performance liquid chromatography
FC Cheng et al.
JOURNAL OF CHROMATOGRAPHY A (2002)
Share Paper
